Skip to content
OpenCapital
Get started

Tarsus Pharmaceuticals, Inc. TARS Number of securities with contractual maturity between one and three years

Number of securities with contractual maturity between one and three years at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
27%0.0pp
HTF
Heartflow, Inc. Common StockHTFL
$96.58M—
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
6%0.0pp
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
67%0.0pp
KKR & Co. logo
KKR & Co.KKR
$596.35M-46.4%
American International Group logo
American International GroupAIG
4.2K-18.9%

Other financials

Income statement

See full
Revenue$162.1M+107%
Gross profit$152.7M+109%
Operating income-$6.1M+76.7%
Net income-$7.0M+72.3%
EPS (diluted)-$0.16+75.0%

Balance sheet

See full
Cash & equivalents$104.2M-41.6%
Total debt$88.7M+22.5%
Total equity$349.0M+1.9%
Total assets$581.1M+16.1%

Cash flow

See full
Operating cash flow-$24.7M-19.4%
CapEx$5.8M+886%
Free cash flow-$30.5M-43.4%

Valuation

See full
Market cap$2.85B+41.1%
Enterprise value$2.83B+47.8%
P/S5.3×-3.3×

Profitability

See full
Gross margin42.7%—
Operating margin-9.5%-4.2pp
Net margin-9%-4.0pp
FCF margin-28%-12.6pp

Returns & leverage

See full
Return on equity-14%-5.2pp
Debt / equity0.3×0.0×
Current ratio3.7×-1.8×

Where this comes from

Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept tars:DebtSecuritiesAvailableForSaleContractualMaturitiesGreaterThanTwelveMonthsNumberOfSecurities.

The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tarsus Pharmaceuticals, Inc.'s number of securities with contractual maturity between one and three years.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tarsus Pharmaceuticals, Inc.'s number of securities with contractual maturity between one and three years?
Tarsus Pharmaceuticals, Inc. (TARS) reported number of securities with contractual maturity between one and three years of 29 in Q1 2026.
How has Tarsus Pharmaceuticals, Inc.'s number of securities with contractual maturity between one and three years changed year-over-year?
Tarsus Pharmaceuticals, Inc.'s number of securities with contractual maturity between one and three years increased by 262.5% year-over-year, from 8 to 29.
What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s number of securities with contractual maturity between one and three years?
Over 3 years (2022 to 2025), Tarsus Pharmaceuticals, Inc.'s number of securities with contractual maturity between one and three years has grown at a 88.2% compound annual growth rate (CAGR), from 3 to 20.
What does number of securities with contractual maturity between one and three years mean?
The total value of debt securities held in the available-for-sale portfolio that are scheduled to mature between one and three years from the reporting date. This metric helps investors evaluate the company's liquidity profile and interest rate risk exposure over the medium term.